Sleep VS for Sleeplessness

"Almost 6 million Americans have insomnia, with one in five adults suffering from daytime sleepiness. The American Medical Association considers excessive daytime sleepiness to be a major public health concern. In a 2007 survey of nearly 4,000 adults, it was found that nearly 8% of subjects had excessive daytime sleepiness. The frequency of sleep disorders differs by region as well. The prevalence of insomnia varies by age, with nearly one in seven adults reporting sleep disturbance. This is a more serious problem among middle-aged and older adult groups, as well. In addition to sleepiness during the day, people who report sleeping during the night also had higher levels of sleepiness during the day." - Anonymous Online Contributor

"Insomnia is a chronic sleep disturbance characterised by excessive daytime sleepiness. It is strongly related to other sleep disorders and behavioural, psychosocial and clinical disorders but the underlying pathophysiology is not fully understood. Insomnia affects 3% of men in the USA and is thought to contribute significantly to general morbidity and economic cost. This article describes the main clinical characteristics and diagnostic procedures used to identify sleeplessness and sleep disorders. The authors urge that the term 'drowsiness' used at present to describe insomnia should be replaced by'severe sleepiness' in clinical trials and the literature to avoid inappropriate treatment with hypnotics and sleep augmentation." - Anonymous Online Contributor

"Insomnia is a symptom of many conditions, and its presence should prompt medical evaluation. Insufficient sleep is associated with an increased body mass index and waist circumference, two well-known risk factors for heart disease. Insomnia and daytime sleepiness may also be indicative of medical conditions such as depression, Alzheimer's disease, epilepsy, migraine, narcolepsy and sleep apnea." - Anonymous Online Contributor

"Insomnia is a symptom of many disorders, but most commonly of the following: insomnia of a primary origin, secondary to other CNS problems, secondary to medication side effects, and secondary to excessive daytime sleepiness or sleep disordered breathing. Insomnia is seen in many groups of people, but some of its most consistent and alarming characteristics are that it is relatively common, it is chronic, it has major adverse effects on health and quality of life, and it can be a significant public health problem in societies. This paper gives recommendations for clinicians to help patients better manage insomnia that is caused by these common disorders and for individuals to develop effective, personalized coping strategies to help them get the rest they need to achieve and maintain higher-quality sleep." - Anonymous Online Contributor

"Results from a recent paper, the majority of participants reported an improvement in their sleep, regardless of whether their baseline score was above or below a certain cut-off point. For participants with severe insomnia, a meaningful improvement was observed regardless of baseline score. In all, 42% of participants reported an improvement of their sleep quality following pharmacotherapy." - Anonymous Online Contributor

"Treatment of insomnia often involves multiple methods. A low- to moderate-risk category of antidepressants also may be effective, depending on severity. Many patients benefit from a combination of relaxation and cognitive behavioural therapy. In some, cognitive behavioural therapy alone may be effective. The benefit and necessity of discontinuing hypnotic drugs, and the role of medications in the long-term management of insomnia remain to be determined." - Anonymous Online Contributor

"QoL improves in people with insomnia compared to people without. Insomnia is associated with a decreased HRQoL and a decreased QoL regardless of the presence or absence of psychiatric diagnoses, especially depressive symptoms. Patients should be approached by their sleep specialist and offered behavioral or pharmacological sleep therapies that maximize HRQoL in addition to improvement in sleep quality." - Anonymous Online Contributor

"In a large number of clinical studies using an objective sleep measurement, and a placebo control with a well-established standard treatment, no significant benefits were found over a placebo with respect to sleep duration or bedtime (even if the treatments were individually administered in a systematic way at specific times according to sleep chronometry measures)." - Anonymous Online Contributor

"It is imperative for people to make a conscious effort throughout the day to switch off the work-related activities completely. To put it another way: Sleep-related activities are not only to be avoided but, rather, all activities as stressful as daily chores and chores should always be avoided. For a long time, I kept a diary and wrote down when I slipped on track of time or when I woke up before 6 to be sure I did all these things and I managed not to fall asleep during all my other activities like school. As a result, I still slept all the time and did not spend that much time around other people. This is not a new skill I learned from other people, but it was new to me." - Anonymous Online Contributor

"Over one third of the patients with insomnia in this study suffered from insomnia symptoms. The majority had insomnia at least four times a week. Of those, 20% of the insomnia symptoms were as severe as those recorded in the DSM-IV in the DSM category of major depressive disorder (MDD)." - Anonymous Online Contributor

"Sleep may improve pain and other symptoms in patients with cancer. Further, an improvement in subjective pain-related quality of life was observed after sleep. However, this beneficial effect can be achieved with any of the typically used treatments, such as non-steroidal antiinflammatory drugs, analgesics, and even a low dose of steroids." - Anonymous Online Contributor

"The use of a TTM in a sleep study is supported by the results of a systematic review of published studies. Moreover, studies have found a significant correlation between improvement of daytime insomnia and improvement in sleep and the number of hours in sleep has increased in recent studies. Therefore, evidence suggests that this approach is useful as a complementary tool to the evaluation of both the pharmacological and non-pharmacological therapies available now, which, in turn, may improve daytime sleepiness. On the other hand, the use of a TTM as a complementary therapy to the clinical and pharmacological evaluation in patients affected by non-adrenergic, non-cholinergic, central, and neurological disorders is still poorly established." - Anonymous Online Contributor